The efficacy of L-carnitine addition in treatment of major depressive disorder

Phase 2

Recruiting

• Conditions: Condition 1: Major depressive disorder. Condition 2: Major depressive disorder.; F33.2; Major depressive disorder, single episode; Major depressive disorder, recurrent severe without psychotic features

• Registration Number: IRCT20150630022991N15
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Diagnosis of major depressive disorder based on diagnostic and statistical manual of mental disorders, 5th edition (DSM-5) through a psychiatrist clinical interview
Age 18 years and over

Exclusion Criteria

Previous history of high mood (mania and/ or hypomania)
Presence of dementia
Cognitive dysfunction
Acute psychiatric disorders based on the opinion of a psychiatrist
Serious somatic disorders
Substance dependence, except cigarettes and caffeine
Consumption of drugs that makes the incidence of depression in the patient

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of depression. Timepoint: At baseline, the third and sixth weeks after the treatment. Method of measurement: Based on Beck depression scale.

Secondary Outcome Measures

Name	Time	Method
Drug side effects. Timepoint: At baseline, the third and sixth weeks after the treatment. Method of measurement: Medical visit.